HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 14, 14024-14032, April 2, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/14/14024    most recent M312152200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Planque, S. Articles by Paul, S. Search for Related Content PubMed PubMed Citation Articles by Planque, S. Articles by Paul, S. Social Bookmarking                      What's this?

Ontogeny of Proteolytic Immunity

IgM SERINE PROTEASES^*

Stephanie Planque, Yogesh Bangale, Xiao-Tong Song, Sangeeta Karle, Hiroaki Taguchi, Brian Poindexter, Roger Bick, Allen Edmundson, Yasuhiro Nishiyama, and Sudhir Paul

From the Chemical Immunology and Therapeutics Research Center, Department of Pathology and Laboratory Medicine, University of Texas, Houston Medical School, Houston, Texas 77030 and the Crystallography Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104

We report the chemical activity of immunoglobulin µ and / subunits expressed on the surface of B cells and in secreted IgM antibodies (Abs) found in the preimmune repertoire. Most of the nucleophilic reactivity of B cells measured by formation of covalent adducts of a hapten amidino phosphonate diester was attributed to µ and / subunits of the B cell receptor. Secreted IgM Abs displayed superior nucleophilic reactivity than IgG Abs. IgM Abs catalyzed the cleavage of model peptide substrates at rates up to 344-fold greater than IgG Abs. Catalytic activities were observed in polyclonal IgM Abs from immunologically naïve mice and humans without immunological disease, as well as monoclonal IgM Abs to unrelated antigens. Comparison of several IgM Abs indicated divergent activity levels and substrate preferences, with the common requirement of a basic residue flanking the cleavage site. Fab fragments of a monoclonal IgM Ab expressed catalytic activity, confirming the V domain location of the catalytic site. The catalytic reaction was inhibited by the covalently reactive hapten probe and diisopropylfluorophosphate, suggesting a serine protease-like mechanism. These observations indicate the existence of serine protease-like BCRs and secreted IgM Abs as innate immunity components with potential roles in B cell development and Ab effector functions.

Received for publication, November 5, 2003 , and in revised form, January 9, 2004.

^* This work was supported by National Institutes of Health Grants AI31268 and CA80312. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Chemical Immunology and Therapeutics Research Center, Department of Pathology and Laboratory Medicine, University of Texas, Houston Medical School, 6431 Fannin, Houston, TX 77030. Fax: 713-500-0574; E-mail: Sudhir.Paul{at}uth.tmc.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Taguchi, S. Planque, G. Sapparapu, S. Boivin, M. Hara, Y. Nishiyama, and S. Paul Exceptional Amyloid {beta} Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds J. Biol. Chem., December 26, 2008; 283(52): 36724 - 36733. [Abstract] [Full Text] [PDF]

				B. Wootla, S. Dasgupta, J. D. Dimitrov, J. Bayry, H. Levesque, J.-Y. Borg, A. Borel-Derlon, D. N. Rao, A. Friboulet, S. V. Kaveri, et al. Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia J. Immunol., June 1, 2008; 180(11): 7714 - 7720. [Abstract] [Full Text] [PDF]

				S. Planque, M. A. Escobar, K. C. Smith, H. Taguchi, Y. Nishiyama, E. Donnachie, K. P. Pratt, and S. Paul Covalent Inactivation of Factor VIII Antibodies from Hemophilia A Patients by an Electrophilic FVIII Analog J. Biol. Chem., May 2, 2008; 283(18): 11876 - 11886. [Abstract] [Full Text] [PDF]

				H. Taguchi, S. Planque, Y. Nishiyama, J. Symersky, S. Boivin, P. Szabo, R. P. Friedland, P. A. Ramsland, A. B. Edmundson, M. E. Weksler, et al. Autoantibody-catalyzed Hydrolysis of Amyloid {beta} Peptide J. Biol. Chem., February 22, 2008; 283(8): 4714 - 4722. [Abstract] [Full Text] [PDF]

				Y. Nishiyama, Y. Mitsuda, H. Taguchi, S. Planque, M. Salas, C. V. Hanson, and S. Paul Towards Covalent Vaccination: IMPROVED POLYCLONAL HIV NEUTRALIZING ANTIBODY RESPONSE INDUCED BY AN ELECTROPHILIC gp120 V3 PEPTIDE ANALOG J. Biol. Chem., October 26, 2007; 282(43): 31250 - 31256. [Abstract] [Full Text] [PDF]

				S. Lacroix-Desmazes, J. Bayry, S. V. Kaveri, D. Hayon-Sonsino, N. Thorenoor, J. Charpentier, C.-E. Luyt, J.-P. Mira, V. Nagaraja, M. D. Kazatchkine, et al. From the Cover: High levels of catalytic antibodies correlate with favorable outcome in sepsis PNAS, March 15, 2005; 102(11): 4109 - 4113. [Abstract] [Full Text] [PDF]

				S. Paul, S. Karle, S. Planque, H. Taguchi, M. Salas, Y. Nishiyama, B. Handy, R. Hunter, A. Edmundson, and C. Hanson Naturally Occurring Proteolytic Antibodies: SELECTIVE IMMUNOGLOBULIN M-CATALYZED HYDROLYSIS OF HIV gp120 J. Biol. Chem., September 17, 2004; 279(38): 39611 - 39619. [Abstract] [Full Text] [PDF]